Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents-Reference-Cited by-同舟云学术

Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents

Published:2018-11 Issue: Volume:205 Page:77-86
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Chung Christine J.,Kirtane Ajay J.,Zhang Yiran,Witzenbichler Bernhard,Weisz Giora,Stuckey Thomas D.,Brodie Bruce R.,Rinaldi Michael J.,Neumann Franz-Josef,Metzger D. Christopher,Henry Timothy D.,Cox David A.,Duffy Peter L.,Mazzaferri Ernest L.,Mehran Roxana,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement;Hochholzer;J Am Coll Cardiol,2006

2. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

3. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

4. Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy;Warner;Br J Clin Pharmacol,2011

5. P2Y12, a new platelet ADP receptor, target of clopidogrel;Herbert;Semin Vasc Med,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current concepts and novel targets for antiplatelet therapy;Nature Reviews Cardiology;2023-04-04

2. Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?;Journal of Clinical Medicine;2022-12-04

3. Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation;JACC: Cardiovascular Interventions;2022-11

4. Acute coronary syndromes and percutaneous coronary intervention—current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?;Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease;2021

5. Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease;Pharmacology;2019-10-22